Kim Dalhoff

5.1k total citations
194 papers, 3.6k citations indexed

About

Kim Dalhoff is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Emergency Medicine. According to data from OpenAlex, Kim Dalhoff has authored 194 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmacology, 35 papers in Pediatrics, Perinatology and Child Health and 33 papers in Emergency Medicine. Recurrent topics in Kim Dalhoff's work include Drug-Induced Hepatotoxicity and Protection (35 papers), Poisoning and overdose treatments (32 papers) and Pharmacogenetics and Drug Metabolism (18 papers). Kim Dalhoff is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (35 papers), Poisoning and overdose treatments (32 papers) and Pharmacogenetics and Drug Metabolism (18 papers). Kim Dalhoff collaborates with scholars based in Denmark, United States and Norway. Kim Dalhoff's co-authors include Lars E. Schmidt, Henrik E. Poulsen, Henrik Horwitz, Bente Glintborg, Jón Trærup Andersen, Stig Ejdrup Andersen, Kjeld Schmiegelow, Tonny Studsgaard Petersen, Niels Tygstrup and Niels Morling and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Kim Dalhoff

181 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Dalhoff Denmark 32 922 613 582 508 455 194 3.6k
Richard Bertz United States 29 774 0.8× 481 0.8× 373 0.6× 580 1.1× 602 1.3× 113 3.6k
Roger K. Verbeeck Belgium 36 1.4k 1.5× 396 0.6× 647 1.1× 569 1.1× 807 1.8× 156 4.7k
Steven C. Curry United States 34 1.2k 1.3× 575 0.9× 684 1.2× 491 1.0× 329 0.7× 132 4.1k
Xavier Vidal Spain 37 358 0.4× 604 1.0× 281 0.5× 1.3k 2.5× 361 0.8× 123 4.9k
Joseph Bertino United States 44 1.4k 1.5× 294 0.5× 791 1.4× 1.2k 2.4× 782 1.7× 212 6.1k
Dario Cattaneo Italy 38 230 0.2× 394 0.6× 747 1.3× 810 1.6× 795 1.7× 233 5.8k
Jordi Camps Spain 46 772 0.8× 934 1.5× 1.4k 2.5× 1.7k 3.4× 248 0.5× 252 7.1k
Eleni Aklillu Sweden 42 2.5k 2.7× 231 0.4× 922 1.6× 855 1.7× 949 2.1× 174 6.3k
E A Roberts Canada 19 723 0.8× 456 0.7× 590 1.0× 1.4k 2.7× 1.5k 3.3× 34 9.5k
W. Stephen Waring United Kingdom 37 558 0.6× 155 0.3× 675 1.2× 358 0.7× 286 0.6× 147 4.1k

Countries citing papers authored by Kim Dalhoff

Since Specialization
Citations

This map shows the geographic impact of Kim Dalhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Dalhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Dalhoff more than expected).

Fields of papers citing papers by Kim Dalhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Dalhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Dalhoff. The network helps show where Kim Dalhoff may publish in the future.

Co-authorship network of co-authors of Kim Dalhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Dalhoff. A scholar is included among the top collaborators of Kim Dalhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Dalhoff. Kim Dalhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heerfordt, Ida M., Kim Dalhoff, Jón Trærup Andersen, et al.. (2025). Response by Windfeld-Mathiasen et al to Letter Regarding Article, “Cardiovascular Disease in Anabolic Androgenic Steroid Users”. Circulation. 152(16). e296–e297.
2.
Heerfordt, Ida M., Kim Dalhoff, Jón Trærup Andersen, et al.. (2025). Cardiovascular Disease in Anabolic Androgenic Steroid Users. Circulation. 151(12). 828–834. 13 indexed citations
3.
Christensen, Louise Westberg Strejby, Helle Gybel Juul‐Larsen, Line Jee Hartmann Rasmussen, et al.. (2025). Enhancing patient stratification methods for medication review during acute admissions. British Journal of Clinical Pharmacology. 91(11). 3279–3287. 1 indexed citations
4.
Heerfordt, Ida M., et al.. (2025). Disability pension among androgenic-anabolic steroid users. Scandinavian Journal of Public Health. 150359753–150359753.
5.
Kristensen, Jonas Henrik, Rasmus Bo Hasselbalch, Morten Østergaard, et al.. (2025). Exploring the Role of Cardiac Troponin-Specific Autoantibodies: Prolonged Cardiac Troponin Elimination, Reduced Clearance, and Variable Interference across 5 Commercial Assays. Clinical Chemistry. 71(9). 970–979. 1 indexed citations
6.
Christensen, Louise Westberg Strejby, et al.. (2025). Efficacy of an interprofessional medication review among acutely admitted older medical patients: A randomized controlled trial. British Journal of Clinical Pharmacology. 92(4). 1221–1231.
7.
Markvart, Merete, et al.. (2025). Analgesic Overdose in Patients With Dental Pain. A Cross‐Sectional Study in Two Dental Emergency Clinics. Basic & Clinical Pharmacology & Toxicology. 136(2). e14124–e14124.
8.
Heerfordt, Ida M., et al.. (2024). Mortality Among Users of Anabolic Steroids. JAMA. 331(14). 1229–1229. 21 indexed citations
9.
Dalhoff, Kim, et al.. (2024). Should high‐dose N‐acetylcysteine be given in cases of massive paracetamol overdoses: A narrative review. Basic & Clinical Pharmacology & Toxicology. 135(3). 285–294. 1 indexed citations
10.
Heerfordt, Ida M., et al.. (2024). Excessive androgen exposure and risk of malignancies: A cohort study. Andrology. 13(2). 296–301. 3 indexed citations
11.
Heerfordt, Ida M., et al.. (2024). Extensive androgen exposure and meningioma risk – A matched cohort study. Clinical Neurology and Neurosurgery. 239. 108217–108217. 5 indexed citations
12.
Houlind, Morten Baltzer, Henrik Berg Rasmussen, Jens Borggaard Larsen, et al.. (2024). Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & Clinical Pharmacology & Toxicology. 134(5). 756–763. 3 indexed citations
13.
Krogh, Niels Steen, Catherine Rechnitzer, Jesper Brok, et al.. (2020). Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process. JMIR mhealth and uhealth. 8(7). e18564–e18564. 19 indexed citations
14.
Petersen, K., Troels Riis, Niklas Worm Andersson, et al.. (2020). High‐Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta‐Adrenoceptor Blockade: A Randomized Clinical Trial. Journal of the American Heart Association. 9(21). 16 indexed citations
15.
Petersen, K., Niklas Rye Jørgensen, Tonny Studsgaard Petersen, et al.. (2018). Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial. Clinical Chemistry and Laboratory Medicine (CCLM). 56(12). 2047–2057. 4 indexed citations
16.
Dalhoff, Kim, Tonny Studsgaard Petersen, Troels Riis, et al.. (2018). Higher chlorzoxazone clearance in obese children compared with nonobese peers. British Journal of Clinical Pharmacology. 84(8). 1738–1747. 16 indexed citations
17.
Mikus, Gerd, et al.. (2016). The CYTONOX trial.. PubMed. 63(5). 5 indexed citations
18.
Hannerz, Harald, Kim Dalhoff, Hermann Burr, & Ute Latza. (2014). Correlation between relative rates of hospital treatment or death due to ischaemic heart disease (IHD) and of IHD-related medication among socio-occupational and economic activities groups in Denmark, 1996–2005. International Journal of Occupational Medicine and Environmental Health. 27(4). 536–46. 5 indexed citations
19.
Clemmesen, Jens Otto, Annamaria Giraldi, Peter Ott, et al.. (2008). Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis. World Journal of Gastroenterology. 14(40). 6208–6208. 30 indexed citations
20.
Schmidt, Lars E. & Kim Dalhoff. (2002). Concomitant overdosing of other drugs in patients with paracetamol poisoning. British Journal of Clinical Pharmacology. 53(5). 535–541. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Bertz Breakdown of academic impact, for papers by Roger K. Verbeeck Breakdown of academic impact, for papers by Steven C. Curry Breakdown of academic impact, for papers by Xavier Vidal Breakdown of academic impact, for papers by Joseph Bertino Breakdown of academic impact, for papers by Dario Cattaneo Breakdown of academic impact, for papers by Jordi Camps Breakdown of academic impact, for papers by Eleni Aklillu Breakdown of academic impact, for papers by E A Roberts Breakdown of academic impact, for papers by W. Stephen Waring
Rankless by CCL
2026